New quinolones and gram-positive bacteria
Open Access
- 1 February 1994
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (2), 163-169
- https://doi.org/10.1128/aac.38.2.163
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- The molecular basis of quinolone actionJournal of Antimicrobial Chemotherapy, 1992
- Absence of bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditionsJournal of Antimicrobial Chemotherapy, 1992
- In-vitro activity of PD 131628, a new quinolone antimicrobial agentJournal of Antimicrobial Chemotherapy, 1992
- Selection of quinlone-resistant mutants of Haemophilus influenzae and Streptococcus pnecumonieaJournal of Antimicrobial Chemotherapy, 1992
- Uptake of 3H-norfloxacin in methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1991
- A point mutation in gene is responsible for quinolone resistance inBiochemical and Biophysical Research Communications, 1990
- In-vitro activity of sparfloxacin, a new quinolone antimicrobial agentJournal of Antimicrobial Chemotherapy, 1990
- Use of a ribosomal RNA gene probe for the epidemiological study of methicillin and ciprofloxacin resistantStaphylococcus aureusEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agentsJournal of Antimicrobial Chemotherapy, 1989
- CIPROFLOXACIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1985